RNS Number:0544S
Arana Therapeutics Limited
10 April 2008


For Immediate Release                                             10 April 2008

                           Arana Therapeutics Limited

                          Notification of Shareholding

Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer advises that on 10 April 2008 Lim Sen Yap has advised the
Australian Securities Exchange (www.asx.com.au) (ASX) that himself and his
associates (as defined under the Corporations Act 2001 (Australia)) held a total
of 27,378,853 ordinary shares in the Company (11.65% of the issued share capital
of the Company) as at 4 April 2008, compared with 24,984,089 ordinary shares of
the Company (10.63% of the issued share capital of the Company) advised to the
ASX on 26 February 2008. A copy of the notice filed by Lim Sen Yap today is
attached.



For further information, please contact:

Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer             +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer             +61 (0)2 8061 9900

Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich                 +44 (0)20 7466 5000

Nomura Code Securities
Charles Walker                                      +44 (0)20 7776 1206






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLGCGDSUDBGGIG
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Arana Therap. Charts.
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Arana Therap. Charts.